Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruihui Xie

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Molecular Cancer|June 22, 2019
A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancerPeng Gu, Xu Chen, Ruihui Xie, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2020
Loss of GATA6 expression promotes lymphatic metastasis in bladder cancerChanjuan Wang, Qinghua Liu, Ming Huang, et al.
Advanced Healthcare Materials|May 27, 2025
Inflammation-Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug CarrierBingliang Chen, Liying Wang, Ruihui Xie, et al.
Molecular Cancer|May 19, 2019
Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axisWei Dong, Junming Bi, Hongwei Liu, et al.
Theranostics|March 23, 2021
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancerQianghua Zhou, Xu Chen, Haixia He, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2020
NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMARRuihui Xie, Xu Chen, Liang Cheng, et al.
Journal of Translational Medicine|April 27, 2025
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancerRuilin Zhuang, Ruihui Xie, Shirong Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Long Noncoding RNA <i>LBCS</i> Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2Xu Chen, Ruihui Xie, Peng Gu, et al.
Cancer Research|March 20, 2023
NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder CancerRuihui Xie, Liang Cheng, Ming Huang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2017
lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5Peng Gu, Xu Chen, Ruihui Xie, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Molecular Cancer|June 22, 2019
A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancerPeng Gu, Xu Chen, Ruihui Xie, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 28, 2020
Loss of GATA6 expression promotes lymphatic metastasis in bladder cancerChanjuan Wang, Qinghua Liu, Ming Huang, et al.
Advanced Healthcare Materials|May 27, 2025
Inflammation-Targeted and Antioxidative Poly(Ferulic Acid) Nanoparticles Directly Treat Chronic Nonbacterial Prostatitis via Inhibiting Pyroptosis by Disrupting Nrf2/KEAP1 Multimer Formation and as a Robust Drug CarrierBingliang Chen, Liying Wang, Ruihui Xie, et al.
Molecular Cancer|May 19, 2019
Circular RNA ACVR2A suppresses bladder cancer cells proliferation and metastasis through miR-626/EYA4 axisWei Dong, Junming Bi, Hongwei Liu, et al.
Theranostics|March 23, 2021
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancerQianghua Zhou, Xu Chen, Haixia He, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 20, 2020
NONO Inhibits Lymphatic Metastasis of Bladder Cancer via Alternative Splicing of SETMARRuihui Xie, Xu Chen, Liang Cheng, et al.
Journal of Translational Medicine|April 27, 2025
An anti-androgen resistance-related gene signature acts as a prognostic marker and increases enzalutamide efficacy via PLK1 inhibition in prostate cancerRuilin Zhuang, Ruihui Xie, Shirong Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2018
Long Noncoding RNA <i>LBCS</i> Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2Xu Chen, Ruihui Xie, Peng Gu, et al.
Cancer Research|March 20, 2023
NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder CancerRuihui Xie, Liang Cheng, Ming Huang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2017
lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5Peng Gu, Xu Chen, Ruihui Xie, et al.
Pageof 3